Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
3 Mar 22
10-Q
2021 Q3
Quarterly report
2 Nov 21
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11 Mar 24
8-K
Departure of Directors or Certain Officers
6 Feb 24
8-K
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
26 Dec 23
8-K
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives
14 Nov 23
8-K
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
21 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
14 Sep 23
8-K
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring
10 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
8-K
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments
10 May 23
8-K
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
29 Mar 23
Registration and prospectus
POS AM
Prospectus update (post-effective amendment)
22 Mar 24
POS AM
Prospectus update (post-effective amendment)
22 Mar 24
25
Voluntary exchange delisting
20 Mar 24
424B3
Prospectus supplement
17 Aug 23
S-3/A
Shelf registration (amended)
16 Aug 23
S-3
Shelf registration
19 Jul 23
S-8
Registration of securities for employees
29 Mar 23
S-8
Registration of securities for employees
23 Mar 22
S-8
Registration of securities for employees
26 Feb 21
424B5
Prospectus supplement for primary offering
12 Aug 20
Proxies
DEFA14A
Additional proxy soliciting materials
26 Mar 24
DEFA14A
Additional proxy soliciting materials
11 Mar 24
DEFM14A
Proxy related to merger
23 Feb 24
PREM14A
Preliminary proxy related to merger
5 Jan 24
DEFA14A
Additional proxy soliciting materials
26 Dec 23
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
28 Apr 21
Other
EFFECT
Notice of effectiveness
25 Mar 24
EFFECT
Notice of effectiveness
25 Mar 24
EFFECT
Notice of effectiveness
18 Aug 23
CORRESP
Correspondence with SEC
16 Aug 23
CORRESP
Correspondence with SEC
27 Jul 23
CORRESP
Correspondence with SEC
26 Jul 23
UPLOAD
Letter from SEC
21 Jul 23
EFFECT
Notice of effectiveness
13 Jul 20
EFFECT
Notice of effectiveness
13 Jul 20
UPLOAD
Letter from SEC
13 Jul 20